Scalper1 News
Biotech Auxilium Pharmaceuticals (AUXL) on Friday received FDA approval to expand the label for its drug Xiaflex, sending its stock up 9.5% in afternoon trading on the stock market today. Xiaflex was approved as the first non-surgical treatment for Peyronie’s disease, which causes curvature of the penis. Xiaflex was first approved in 2010 to treat a similar disease of the hands called Dupuytren’s contracture, but that’s translated to only about Scalper1 News
Scalper1 News